Posted inMedical Device
B. Braun Bloodline Alert: How a Missed Assembly Step Became an FDA Notice
The B. Braun Streamline Bloodline Set FDA alert traces a missed solvent step to a connector risk. What is known, and what the FDA is still reviewing.
Posted inPharmaceutical
Novartis Q3 2026 Results: What the Del-Desiran Write-Down Says About Pipeline Risk
What the Novartis Q3 2026 results reveal about its drug pipeline, the Avidity deal and rare-disease risk after the HARBOR trial miss.
Posted inHealthcare Services
Indira IVF Sabine Acquisition: What It Would Mean for Kerala Fertility Care
What the Indira IVF Sabine acquisition would mean for Kerala fertility care, rival chains and patients, and what is still unconfirmed.
Posted inPharmaceutical
AstraZeneca Stomach Cancer Drug Trial: Why Progression-Free Survival Missed
The AstraZeneca stomach cancer drug trial won on survival but missed progression-free survival at p=0.053. How to read both results.
Posted inPharmaceutical
Takeda Gastric Cancer Drug Trial: Who Benefits From the Claudin 18.2 ADC
Who does the Takeda gastric cancer drug trial apply to? Claudin 18.2-positive, heavily pretreated patients in Japan and China. Data and limits.
Posted inPharmaceutical
Roche Divarasib Phase 3 Trial: How to Read the KRASCENDO 1 Results
The Roche divarasib Phase 3 trial explained: who was enrolled, which drugs it beat, what is interim and what remains unknown.
Posted inHealthcare Services
Paras Healthcare IPO Subscription: Institutions Lead, NII Portion Lags
The Paras Healthcare IPO subscription was led by institutions at 3.25 times; retail bid 2.10 times and NIIs 0.69 times. Valuation and dates.
Posted inHealthcare Services
Talkiatry Therapy Services Nationwide: What Virtual Combined Care Means
The Talkiatry therapy services nationwide add in-network therapy to virtual psychiatry in 50 states. Company claims, telehealth context, open questions.
Posted inHealthcare IT
Healthcare AI Adoption Survey 2026: North America Trails on AI Strategy
The healthcare AI adoption survey 2026 shows North America trailing on clinical AI strategy: 68% versus 84% in EMEA and 85% in APAC.
Posted inHealthcare IT
FDA Prescription Drug Software Guidance: When an App Becomes Drug Labeling
The FDA prescription drug software guidance treats drug-linked app output as labeling. How device-connected and standalone apps are handled.